/
PGNY
$28.86+$0.35 (+1.23%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.2B
78M shares
52-week range
$16.10 – $28.99
99% from low
Sector
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Exchange
NASDAQ
CS
Borrow rate
0.30%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-30.14
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $105.4M | $229.7M | $344.9M | $500.6M | $786.9M | $1.09B | $1.17B | $1.29B |
| Cost of revenue | $86.0M | $184.2M | $274.8M | $388.5M | $619.6M | $849.8M | $913.9M | $984.2M |
| Gross profit | $19.4M | $45.5M | $70.1M | $112.1M | $167.3M | $238.8M | $253.4M | $304.5M |
| Gross margin | 18.4% | 19.8% | 20.3% | 22.4% | 21.3% | 21.9% | 21.7% | 23.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$3.5M | $9.7M | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | $85.3M |
| EBITDA | −$1.6M | $11.8M | $10.3M | $33.7M | $26.0M | $73.0M | $86.4M | $100.4M |
| Net income | $661.0K | −$8.6M | $46.5M | $65.8M | $30.4M | $62.0M | $54.3M | $58.5M |
| Net margin | 0.6% | -3.7% | 13.5% | 13.1% | 3.9% | 5.7% | 4.7% | 4.5% |
| EPS (diluted) | 0.01 | -0.10 | 0.47 | 0.66 | 0.30 | 0.62 | 0.57 | 0.65 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.4B | $1.30 | $1.23–$1.36 | 6 |
| 2027 | $1.5B | $1.49 | $1.37–$1.61 | 6 |
| 2028 | $1.6B | $1.64 | $1.35–$1.84 | 3 |
| 2029 | $1.7B | $1.97 | $1.93–$2.01 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$22.78
Price
$28.86
Implied downside
-21%
Peer comparison
Progyny, Inc. Common Stock
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
www.progyny.com- Employees
- 856
- IPO / List date
- Oct 25, 2019
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds PGNY.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 812,067 | $13.8M |
| Bridgewater Associatesas of 2025-09-30 | 65,643 | $1.4M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PGNY yet.
